Joshua Tyler Bonnema Williams, MD | |
13123 E 16th Ave, Mailstop B158, Aurora, CO 80045-7106 | |
(720) 777-1234 | |
(720) 777-7258 |
Full Name | Joshua Tyler Bonnema Williams |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 13123 E 16th Ave, Aurora, Colorado |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447592688 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | DR.0056810 (Colorado) | Secondary |
208000000X | Pediatrics | DR.0056810 (Colorado) | Primary |
Entity Name | Denver Health And Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477569838 PECOS PAC ID: 4688583578 Enrollment ID: O20031105000211 |
News Archive
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die.
Multidisciplinary care teams consisting of clinicians, nurses and other health care professionals appear to be associated with a lower risk of death among patients in the intensive care unit, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. A second report finds that an increasing number of surgical patients are being managed jointly by a surgeon and another clinician, such as a hospitalist or internal medicine sub-specialist.
Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.
Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUSĀ® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Joshua Tyler Bonnema Williams, MD Po Box 110429, Aurora, CO 80042-0429 Ph: (303) 493-7000 | Joshua Tyler Bonnema Williams, MD 13123 E 16th Ave, Mailstop B158, Aurora, CO 80045-7106 Ph: (720) 777-1234 |
News Archive
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of principle, they identified a highly potent compound that causes cancer cells to attack themselves and die.
Multidisciplinary care teams consisting of clinicians, nurses and other health care professionals appear to be associated with a lower risk of death among patients in the intensive care unit, according to a report in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. A second report finds that an increasing number of surgical patients are being managed jointly by a surgeon and another clinician, such as a hospitalist or internal medicine sub-specialist.
Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development and related consulting, highlights additional attendees at the CFA African Healthcare Infrastructure Forum and Brainstorm held at the African Union, in Washington DC, on February 6, 2015.
Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUSĀ® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.
› Verified 1 days ago
Dr. Jonathan Orsborn, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Dr. Joel A. Friedlander, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 Fax: 720-777-7277 | |
Dr. Emily Greenwald, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Children's Hospital Colorado, Aurora, CO 80045 Phone: 720-777-1234 | |
Jessica Boat Landry, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Robert Kramer, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Richard W. Penland, Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 S Potomac St, Aurora, CO 80012 Phone: 303-695-2628 Fax: 303-306-7753 | |
John Roger Hollister, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 |